Opium use and subsequent incidence of cancer: results from the Golestan Cohort Study
Mahdi Sheikh(Centre international de recherche sur le cancer), Reza Malekzadeh(Tehran University of Medical Sciences), Christian C. Abnet(National Institutes of Health), Hooman Khademi(Tehran University of Medical Sciences), Mahdi Zahedi(Golestan University of Medical Sciences), Paolo Boffetta(University of Bologna), Abdolreza Fazel(Golestan University), Farhad Islami(American Cancer Society), Masoud Sotoudeh(Tehran University of Medical Sciences), Ramin Shakeri(Tehran University of Medical Sciences), Arash Etemadi(National Institutes of Health), Masoud Khoshnia(Shariati Hospital), Gholamreza Roshandel(Golestan University), Hossein Poustchi(Shariati Hospital), Akram Pourshams, Behnoush Abedi‐Ardekani(Centre international de recherche sur le cancer), Sadaf G Sepanlou(Tehran University of Medical Sciences), Sanford M. Dawsey(National Cancer Institute), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Neal D. Freedman(National Institutes of Health), Maryam Hashemian(National Cancer Institute), Nicholas Day(Mahidol Oxford Tropical Medicine Research Unit), Paul Brennan(Centre international de recherche sur le cancer), Abdolsamad Gharavi(Shariati Hospital), Farin Kamangar(Department of Health and Human Services)
Cited by 108
Related Papers
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
|Nature Biotechnology|2019|24.2k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet. Gastroenterology & hepatology|2020|1.7k